Observation on the effect of homologous prescription of medicine and food in chronic fatigue syndrome

Phase 1

• Conditions: chronic fatigue syndrome

• Registration Number: ITMCTR2200005527
• Lead Sponsor: ?????????

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1) Male or female participants aged 18-65 who were diagnosed with CFS according to CDC criteria;
2) Have not received any treatment for CFS in the past 1 month
3) Voluntarily provide signed consent forms.
According to CDC standards, CFS patients must show the following symptoms:
A) Persistent or recurrent fatigue for 6 months or more, not related to persistent fatigue or any other medical condition related to fatigue,
B) fatigue and work that significantly interferes with personal activities
C) Four or more concurrent symptoms (impaired short-term memory or concentration; Sore throat; Tenderness of cervical or axillary lymph nodes; Muscle pain; Multiple joint pain without joint swelling or redness; New headache, or severity; Unawake sleep; And discomfort lasting more than 24 hours after exercise).

Exclusion Criteria

1) Male or female participants aged 18-65 who were diagnosed with CFS according to CDC criteria;
2) Have not received any treatment for CFS in the past 1 month
3) Voluntarily provide signed consent forms.
According to CDC standards, CFS patients must show the following symptoms:
A) Persistent or recurrent fatigue for 6 months or more, not related to persistent fatigue or any other medical condition related to fatigue,
B) fatigue and work that significantly interferes with personal activities
C) Four or more concurrent symptoms (impaired short-term memory or concentration; Sore throat; Tenderness of cervical or axillary lymph nodes; Muscle pain; Multiple joint pain without joint swelling or redness; New headache, or severity; Unawake sleep; And discomfort lasting more than 24 hours after exercise).

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The questionnaire survey;